[Surveillance for nosocomial infections in pediatric hematology/oncology patients]

Area of Science:

• Pediatric Hematology-Oncology
• Infectious Diseases
• Hospital Epidemiology

Background:

• Immunocompromised children undergoing hematology-oncology treatment are highly susceptible to nosocomial infections (NI).
• The incidence and specific risk factors for NI in this vulnerable population remain under-investigated.
• The potential for preventing NI through enhanced infection control measures is largely unknown.

Purpose of the Study:

• To highlight the critical need for focused surveillance of nosocomial infections (NI) in pediatric hematology-oncology.
• To identify key areas for infection control interventions within these units.
• To emphasize the role of prospective surveillance in quality improvement.

Main Methods:

• The study proposes a surveillance protocol adapted from Centers for Disease Control and Prevention (CDC) methods.
• Focus areas include device-associated infections (catheter-associated urinary tract infections, central venous catheter infections), nosocomial pneumonia (especially Aspergillus), and viral infections (RSV, Rotavirus).
• Prospective surveillance on pediatric hematology/oncology units is recommended.

Main Results:

• Current data on NI incidence and risk factors in pediatric hematology-oncology patients are insufficient.
• Specific NI types requiring surveillance include device-associated infections, pneumonia, and viral infections.
• Modified CDC definitions are necessary for accurate NI assessment in this population.

Conclusions:

• Prospective surveillance of NI in pediatric hematology-oncology units is essential for internal quality control.
• Evaluating specific NI rates helps identify critical control points for targeted infection control programs.
• Effective surveillance strategies can improve patient outcomes by reducing preventable infections.